Intellectual Property India Publishes Patent Application for 'Drug Conjugates And Methods Of Preparing And Using The Same' Filed by Adcentrx Therapeutics Inc.; and Adcentrx Therapeutics Shanghai Co. Ltd.

MUMBAI, India, Aug. 29 -- Intellectual Property India has published a patent application (202517074810 A) filed by Adcentrx Therapeutics Inc.; and Adcentrx Therapeutics Shanghai Co. Ltd., San Diego, on Aug. 6, for 'drug conjugates and methods of preparing and using the same.'

Inventor(s) include Guo, Maojun; Li, Richard, Hui; Lee, Dong, Jun; Luo, Wenlong; and Wei, Ping.

The application for the patent was published on Aug. 29, under issue no. 35/2025.

According to the abstract released by the Intellectual Property India: "The invention provides novel linkers, linker conjugates, and drug conjugates thereof, as well as methods of preparation and use thereof for treating various diseases and conditions."

The patent application was internationally filed on Jan. 18, 2024, under International application No.PCT/US2024/011923.

Disclaimer: Curated by HT Syndication.